Allo-HLA - Reactive T cells inducing graft-versus-host disease are single peptide specific

Blood

Volumn 118, Issue 26, 2011, Pages 6733-6742

  Amir, Avital L ^a   Van Der Steen, Dirk M ^a   Hagedoorn, Renate S ^a   Kester, Michel G D ^a   Van Bergen, Cornelis A M ^a   Drijfhout, Jan W ^a   De Ru, Arnoud H ^a   Falkenburg, J H Frederik ^a   Van Veelen, Peter A ^a   Heemskerk, Mirjam H M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A2 ANTIGEN; SHORT HAIRPIN RNA;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOIMMUNITY; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL EXPANSION; CELL SPECIFICITY; DOWN REGULATION; DROSOPHILA; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 84255197321     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-05-354787     Document Type: Article

References (32)

1. Rudolph MG, Stanfield RL, Wilson IA. How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol. 2006;24:419-466.
2. Huseby ES, Crawford F, White J, Kappler J, Marrack P. Negative selection imparts peptide specificity to the mature T cell repertoire. Proc Natl Acad Sci U S A. 2003;100(20):11565-11570. (Pubitemid 37205976)
3. Huseby ES, White J, Crawford F, et al. How the T cell repertoire becomes peptide and MHC specific. Cell. 2005;122(2):247-260. (Pubitemid 41032988)
4. Alexander-Miller MA, Burke K, Koszinowski UH, Hansen TH, Connolly JM. Alloreactive cytotoxic T lymphocytes generated in the presence of viral-derived peptides show exquisite peptide and MHC specificity. J Immunol. 1993;151(1):1-10. (Pubitemid 23206965)
5. Aosai F, Ohlen C, Ljunggren HG, et al. Different types of allospecific CTL clones identified by their ability to recognize peptide loading-defective target cells. Eur J Immunol. 1991;21(11):2767-2774.
6. Crumpacker DB, Alexander J, Cresswell P, Engelhard VH. Role of endogenous peptides in murine allogenic cytotoxic T cell responses assessed using transfectants of the antigen-processing mutant 174xCEM.T2. J Immunol. 1992;148(10):3004-3011.
7. Heath WR, Kane KP, Mescher MF, Sherman LA. Alloreactive T cells discriminate among a diverse set of endogenous peptides. Proc Natl Acad Sci U S A. 1991;88(12):5101-5105. (Pubitemid 21914691)
8. Leisegang M, Wilde S, Spranger S, et al. MHC-restricted fratricide of human lymphocytes expressing survivin-specific transgenic T cell receptors. J Clin Invest. 2010;120(11):3869-3877.
9. Obst R, Munz C, Stevanovic S, Rammensee HG. Allo- and self-restricted cytotoxic T lymphocytes against a peptide library: evidence for a functionally diverse allorestricted T cell repertoire. Eur J Immunol. 1998;28(8):2432-2443. (Pubitemid 28362718)
10. Rotzschke O, Falk K, Faath S, Rammensee HG. On the nature of peptides involved in T cell alloreactivity. J Exp Med. 1991;174(5):1059-1071.
11. Weber DA, Terrell NK, Zhang Y, et al. Requirement for peptide in alloreactive CD4+ T cell recognition of class II MHC molecules. J Immunol. 1995;154(10):5153-5164.
12. Weinzierl AO, Rudolf D, Hillen N, et al. Features of TAP-independent MHC class I ligands revealed by quantitative mass spectrometry. Eur J Immunol. 2008;38(6):1503-1510.
13. de Koster HS, Vermeulen CJ, Koning F. The majority of HLA-DR3 alloreactive T cells is peptide specific, but does not recognize known DR3-bound sequences. Tissue Antigens. 1998;51(1):88-95. (Pubitemid 28014549)
14. Felix NJ, Donermeyer DL, Horvath S, et al. Alloreactive T cells respond specifically to multiple distinct peptide-MHC complexes. Nat Immunol. 2007;8(4):388-397. (Pubitemid 46745414)
15. Hourigan CS, Harkiolaki M, Peterson NA, Bell JI, Jones EY, O'Callaghan CA. The structure of the human allo-ligand HLA-B*3501 in complex with a cytochrome p450 peptide: steric hindrance influences TCR allo-recognition. Eur J Immunol. 2006;36(12):3288-3293. (Pubitemid 44932730)
16. Geiger R, Duhen T, Lanzavecchia A, Sallusto F. Human naive and memory CD4+ T cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cells. J Exp Med. 2009;206(7):1525-1534.
17. Turner SJ, Doherty PC, McCluskey J, Rossjohn J. Structural determinants of T-cell receptor bias in immunity. Nat Rev Immunol. 2006;6(12):883-894. (Pubitemid 44851731)
18. Gorczynski RM, Rittenberg MB. Analysis of mixed leucocyte culture (MLC) reactive cells after in vitro priming. Changes in avidity of T cell receptors. Cell Immunol. 1975;16(1):171-181.
19. Walter S, Herrgen L, Schoor O, et al. Cutting edge: predetermined avidity of human CD8 T cells expanded on calibrated MHC/anti-CD28-coated microspheres. J Immunol. 2003;171(10):4974-4978. (Pubitemid 37432775)
20. Amir AL, D'Orsogna LJ, Roelen DL, et al. Allo-HLA reactivity of virus-specific memory T cells is common. Blood. 2010;115(15):3146-3157.
21. Macedo C, Orkis EA, Popescu I, et al. Contribution of naive and memory T-cell populations to the human alloimmune response. Am J Transplant. 2009;9(9):2057-2066.
22. Wilde S, Sommermeyer D, Frankenberger B, et al. Dendritic cells pulsed with RNA encoding allogeneic MHC and antigen induce T cells with superior antitumor activity and higher TCR functional avidity. Blood. 2009;114(10):2131-2139.
23. Heemskerk MH, de Paus RA, Lurvink EG, et al. Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex. Proc Natl Acad Sci U S A. 2001;98(12):6806-6811. (Pubitemid 32538298)
24. Kloosterboer FM, van Luxemburg-Heijs SA, van Soest RA, et al. Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cells. Leukemia. 2004;18(4):798-808. (Pubitemid 38500199)
25. Heemskerk MH, Hoogeboom M, de Paus RA, et al. Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region. Blood. 2003;102(10):3530-3540. (Pubitemid 37409367)
26. Burrows SR, Kienzle N, Winterhalter A, et al. Peptide-MHC class I tetrameric complexes display exquisite ligand specificity. J Immunol. 2000;165(11):6229-6234.
27. Nagarajan UM, Peijnenburg A, Gobin SJ, Boss JM, van den elsen PJ. Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells. J Immunol. 2000;164(7):3666-3674. (Pubitemid 30169821)
28. Borbulevych OY, Piepenbrink KH, Gloor BE, et al. T cell receptor cross-reactivity directed by antigen-dependent tuning of peptide-MHC molecular flexibility. Immunity. 2009;31(6):885-896.
29. Brehm MA, Pinto AK, Daniels KA, et al. T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens. Nat Immunol. 2002;3(7):627-634. (Pubitemid 34752471)
30. Offringa R. Antigen choice in adoptive T-cell therapy of cancer. Curr Opin Immunol. 2009;21(2):190-199.
31. Engelhard VH, Brickner AG, Zarling AL. Insights into antigen processing gained by direct analysis of the naturally processed class I MHC associated peptide repertoire. Mol Immunol. 2002;39(3-4):127-137. (Pubitemid 35013506)
32. Zerrahn J, Held W, Raulet DH. The MHC reactivity of the T cell repertoire prior to positive and negative selection. Cell. 1997;88(5):627-636. (Pubitemid 27152405)